retatrutide clinical trials brazil ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Clinical Trials - ADA Meeting

Jennifer Hardy May 31, 202511 min read How to Safely Dispose Needles from GLP-1 Pens or Vials If this is your first time using injectable medications like GLP-1s, it's tempting to toss the needle or pen in the trash after use

Specifically, it acts as a single peptide that simultaneously activates three receptors involved in metabolic regulation: the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR)

& Winans, S

The DAPA-HF, EMPEROR-REDUCED, EMPEROR-Preserved, DELIVER and other trials mentioned above consistently demonstrate the efficacy of SGLT-2i in patients with HF, regardless of LVEF or the presence of diabetes

doi: 10.1038/s41598-020-59799-2 8 ZhangYHanCZhuWYangGPengXMehtaSet al